About Nectero Medical
Nectero Medical is a company based in Bethlehem (United States) founded in 2019.. Nectero Medical has raised $115.5 million across 3 funding rounds from investors including Boston Scientific, Norwest Venture Partners and BioStar Capital. The company has 6 employees as of December 31, 2021. Nectero Medical offers products and services including Nectero EAST System. Nectero Medical operates in a competitive market with competitors including Mercator MedSystems, PharmaIN, Samyang BioPharm, Advanced NanoTherapies and VESTECK, among others.
- Headquarter Bethlehem, United States
- Employees 6 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nectero Medical Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$115.5 M (USD)
in 3 rounds
-
Latest Funding Round
$96 M (USD), Series D
Apr 04, 2024
-
Investors
Boston Scientific
& 4 more
-
Employee Count
6
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nectero Medical
Nectero Medical offers a comprehensive portfolio of products and services, including Nectero EAST System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Endovascular system to stabilize abdominal aortic aneurysms.
Funding Insights of Nectero Medical
Nectero Medical has successfully raised a total of $115.5M across 3 strategic funding rounds. The most recent funding activity was a Series D round of $96 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series D — $96.0M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Series D - Nectero Medical | Valuation | Norwest Venture Partners | |
| Sep, 2021 | Amount | Series C - Nectero Medical | Valuation | Boston Scientific |
|
| Apr, 2020 | Amount | Series B - Nectero Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nectero Medical
Nectero Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Norwest Venture Partners and BioStar Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
Healthtech startups are funded by BioStar Capital's venture capital efforts.
|
Founded Year | Domain | Location | |
|
Healthcare venture capital investments are made by Cadence Healthcare Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nectero Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nectero Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nectero Medical Comparisons
Competitors of Nectero Medical
Nectero Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mercator MedSystems, PharmaIN, Samyang BioPharm, Advanced NanoTherapies and VESTECK, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Catheter-guided microfluid injection systems are developed for targeted tissue therapies.
|
|
| domain | founded_year | HQ Location |
Proprietary drug delivery platforms are developed for API enhancement.
|
|
| domain | founded_year | HQ Location |
Transdermal drug patches and wound closure devices are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a drug delivery device for cardiac vascular diseases
|
|
| domain | founded_year | HQ Location |
Developer of a device for the treatment of aortic aneurysms
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nectero Medical
Frequently Asked Questions about Nectero Medical
When was Nectero Medical founded?
Nectero Medical was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Nectero Medical located?
Nectero Medical is headquartered in Bethlehem, United States.
Who is the current CEO of Nectero Medical?
Jack Springer is the current CEO of Nectero Medical.
Is Nectero Medical a funded company?
Nectero Medical is a funded company, having raised a total of $115.5M across 3 funding rounds to date.
How many employees does Nectero Medical have?
As of Dec 31, 2021, the latest employee count at Nectero Medical is 6.
What does Nectero Medical do?
Nectero Medical was founded in 2019 and is headquartered in Bethlehem, United States. The company operates in the medical device sector, focusing on cardiovascular treatments. An endovascular aneurysm stabilization system is developed by the firm, through which a stabilizer agent is delivered directly to the aneurysm site. This approach is intended to reduce aneurysm growth rates and enhance aortic tissue strength. Leadership is provided by CEO Jack Springer.
Who are the top competitors of Nectero Medical?
Nectero Medical's top competitors include Mercator MedSystems, PharmaIN and Advanced NanoTherapies.
What products or services does Nectero Medical offer?
Nectero Medical offers Nectero EAST System.
Who are Nectero Medical's investors?
Nectero Medical has 5 investors. Key investors include Boston Scientific, Norwest Venture Partners, BioStar Capital, Cadence Healthcare Ventures, and Aphelion Capital.